Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 618Head and Neck Neoplasms 598Nasopharyngeal Carcinoma 230Thyroid Neoplasms 148Oropharyngeal Neoplasms 104Carcinoma, Squamous Cell 89Salivary Gland Neoplasms 88Mouth Neoplasms 87Nasopharyngeal Neoplasms 79Recurrence 66Carcinoma, Non-Small-Cell Lung 65Laryngeal Neoplasms 60Neoplasm Metastasis 58Neoplasms 49Hypopharyngeal Neoplasms 45Thyroid Carcinoma, Anaplastic 42Thyroid Cancer, Papillary 42Melanoma 38Breast Neoplasms 36Lung Neoplasms 33Adenocarcinoma, Follicular 33Carcinoma 32Tongue Neoplasms 30Sarcoma 29Uterine Cervical Neoplasms 28Stomatitis 28Colorectal Neoplasms 28Carcinoma, Medullary 24Ovarian Neoplasms 23Esophageal Neoplasms 23

Interventions

Microsurgery 1Lasers, Gas 1Laser Therapy 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Laryngeal papillomatosis × Head & Neck × Clear all
NCT00592319 2012-08-31

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Boston University

Phase 2 Terminated
10 enrolled 6 charts
Head & Neck

Laryngeal papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡